Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of February 28, 2021
Mystery solved: How graft-vs.-host disease starts in the gut
Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it
Seattle Times' Pacific NW Magazine profiles Fred Hutch
Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Good News: HIV researcher Julie Overbaugh leads Hutch graduate education ... and more
Celebrating faculty and staff achievements
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
The cancer waiting game: When the recommended treatment is nothing
For patients who choose ‘watch and wait,’ putting off treatment can be a relief — and a source of stress
Bone marrow transplant patients report better quality of life compared to peripheral blood transplant recipients from unrelated volunteer donors
Large, nationwide study finds better psychological well-being, fewer graft vs. host disease symptoms and greater likelihood of returning to work among bone marrow transplant recipients
Good News at Fred Hutch: Immunotherapy pioneer named chair, Nobel laureate keynotes
Celebrating faculty and staff achievements
Crafting a better T cell for immunotherapy
New technology, not yet tested in humans, aims to reduce patients’ waiting time, increase potency of T-cell therapy
Dramatic remissions seen in immunotherapy trial of blood cancer patients
Experimental, living T-cell therapy shows promise for treating advanced disease, making immunotherapy a ‘pillar’ of cancer care
Kids like Rita: A doctor’s drive to save children from deadly blood cancers
Pediatric transplant pioneer Dr. Jean Sanders reflects on a lifetime of dedicated focus, all for ‘her kids’
From building toys to developing cures
At 80, transplant scientist Dr. Rainer Storb can't stop tinkering with — and solving — medical puzzles
Good News at Fred Hutch
<p>CTI BioPharma and Fred Hutch announce international research fellowship in blood cancers; Dr. Julie Overbaugh receives $2.5M NIDA grant for HIV research; Dr. Johnnie Orozco wins grant to develop less-toxic cancer treatment; Dr. Philip Greenberg named editor-in-chief of Cancer Immunology Research; CFO Randy Main receives AIRI lifetime achievement award</p>
'It made me more grateful'
An extraordinary girl contends with a rare, life-threatening blood disease — and undergoes a made-to-order clinical study in cord-blood transplantation
Fred Hutch recruits D. Gary Gilliland as its new president and director
Internationally renowned cancer genetics expert to take the helm in the new year
A life takes flight: Leukemia survivor folds origami cranes to mark 30 years since transplant
Leukemia survivor folds 1,000 origami cranes to celebrate 30 years of life, raise funds
Beginner’s guide to Obliteride
Practical tips and motivating takeaways to help you rock your ride